瀏覽量: 127
- 產(chǎn)品名稱: Research Grade Otelixizumab ( 奧昔組單抗 )
- 產(chǎn)品貨號(hào): CSD00147
- 貨期: 現(xiàn)貨
- 價(jià)格與訂購(gòu): 2480
- 數(shù)量:
- 規(guī)格: 100μg
- 產(chǎn)品信息
- 如何訂購(gòu)
貨號(hào)(Catalog No.)
CSD00147
通用名INN
Otelixizumab
純度(Purity
>95%
濃度( Concentration)
1mg/ml
Formulation
PBS buffer PH7.5
Source
CHO cells
內(nèi)毒素(Endotoxin level)
Please contact with the lab for this information.
產(chǎn)品描述(Description)
Otelixizumab is a monoclonal antibody that binds to a receptor found on all T cells called CD3, which is involved in normal T cell signaling. Otelixizumab is believed to inhibit the function of autoreactive T cells, which are important in propagating autoimmune diseases, while inducing regulatory T cell pathways that promote immunological tolerance and inhibit autoreactive disease activity. Tolerx is developing otelixizumab to treat patients with type 1 diabetes, psoriasis and other autoimmune diseases such as rheumatoid arthritis.
別名(Alternative names)
ChAglyCD,TRX4
靶點(diǎn);物種(Specificity target name;species)
CD3E[Homo sapiens]
種類(Species)
Chimeric,Humanized
受體鑒定(Receptor identification)
IgG1-lambda
分子量(MV)
146158.0 Da
CAS
881191-44-2
存儲(chǔ)條件(Storage)
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Store at +4°C short term (1-2 weeks).
Store at -20 °C 12 months.
Store at -80°C long term.
Note
For research use only .